| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 350.57B | 355.56B | 344.99B | 315.03B | 311.84B | 301.37B |
| Gross Profit | 40.74B | 42.90B | 40.02B | 33.70B | 28.07B | 25.85B |
| EBITDA | 31.02B | 33.06B | 30.33B | 24.63B | 21.51B | 18.68B |
| Net Income | 12.35B | 14.27B | 14.05B | 11.35B | 8.30B | 7.99B |
Balance Sheet | ||||||
| Total Assets | 287.76B | 299.73B | 289.70B | 277.06B | 266.02B | 257.76B |
| Cash, Cash Equivalents and Short-Term Investments | 61.17B | 65.87B | 66.40B | 70.03B | 69.38B | 59.09B |
| Total Debt | 57.52B | 57.64B | 60.85B | 68.20B | 74.56B | 75.38B |
| Total Liabilities | 138.26B | 136.47B | 139.27B | 140.97B | 142.22B | 144.47B |
| Stockholders Equity | 145.75B | 159.08B | 146.78B | 133.27B | 121.30B | 110.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.29B | 14.30B | 10.04B | 14.24B | 8.81B |
| Operating Cash Flow | 0.00 | 24.86B | 23.47B | 17.69B | 18.79B | 16.75B |
| Investing Cash Flow | 0.00 | -16.21B | -16.65B | -7.84B | -5.85B | -6.38B |
| Financing Cash Flow | 0.00 | -10.50B | -13.19B | -9.90B | -3.55B | -15.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥146.10B | 10.77 | ― | 3.65% | 3.06% | 1.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥296.03B | 26.94 | ― | 1.28% | 6.67% | 10.43% | |
60 Neutral | ¥957.96B | 15.06 | 9.97% | 3.54% | 11.19% | 5.65% | |
59 Neutral | ¥345.78B | 15.79 | 8.30% | 2.50% | 5.27% | -5.79% | |
59 Neutral | ¥300.34B | 17.48 | ― | 2.94% | 1.47% | -10.54% | |
56 Neutral | ¥1.18T | 47.02 | ― | 2.99% | -0.90% | -81.16% |